Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients

Published:2014-08-15 Issue:3 Volume:98 Page:312-319
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Vo Ashley A.,Choi Jua,Cisneros Kristen,Reinsmoen Nancy,Haas Mark,Ge Shili,Toyoda Mieko,Kahwaji Joseph,Peng Alice,Villicana Rafael,Jordan Stanley C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. The quality of life of patients with end-stage renal disease.;Evans;N Engl J Med,1985

2. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.;Port;JAMA,1993

3. Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches.;Cecka;Am J Transplant,2011

4. Antibody mediated renal allograft rejection: diagnosis and pathogenesis.;Colvin;J Am Soc Nephrol,2007

5. The spectrum of antibody-mediated renal allograft injury: implications of treatment.;Gloor;Am J Transplant,2008

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024;The Journal of Heart and Lung Transplantation;2024-10

2. Anti-HLA Class II Antibodies Are the Most Resistant to Desensitization in Crossmatch-positive Living-donor Kidney Transplantations: A Patient Series;Transplantation Direct;2024-08-29

3. The Impact of Alloantibodies on Clinical VCA Outcomes and the Need for Immune Tolerance;Transplantology;2024-07-29

4. Desensitization of Highly Immunized Kidney Transplant Recipients Awaiting Transplantation—Polish Single-Center Experience;Transplantation Proceedings;2024-05

5. Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot;Transplantation;2024-01-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3